OBSOLETE: Envenomization by Bothrops lanceolatus

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

2 events
May 2015

Anavip: FDA approved

Management of adult and pediatric patients with North American rattlesnake envenomation

FDAcompleted
Oct 2000

CroFab: FDA approved

Treatment of minimal and moderate North American Crotalidae envenomation

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

2 programs

FINANCIAL LANDSCAPE SUMMARY

2

Total programs

2

Open now

2

Copay cards

Copay Assistance2

Anavip

Rare Disease Therapeutics, Inc.

OpenContact for details

CroFab

Protherics, Inc.

OpenContact for details

View all support programs on disease page →

Approved Treatments

2 FDA-approved

Anavip

(crotalidae immune F(ab')2 (equine))Orphan drug

Rare Disease Therapeutics, Inc.

Approved May 2015

CroFab

(Antivenin, crotalidae polyvalent immune Fab (ovine))Orphan drug

Protherics, Inc.

Approved Oct 2000

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for OBSOLETE: Envenomization by Bothrops lanceolatus.
Search all trials →
Search clinical trials for OBSOLETE: Envenomization by Bothrops lanceolatus

Recent News & Research

No recent news articles indexed yet for OBSOLETE: Envenomization by Bothrops lanceolatus.
Search PubMed for OBSOLETE: Envenomization by Bothrops lanceolatus

Browse all OBSOLETE: Envenomization by Bothrops lanceolatus news →

Specialist Network

No specialists currently listed for OBSOLETE: Envenomization by Bothrops lanceolatus.

View all OBSOLETE: Envenomization by Bothrops lanceolatus specialists →

Quick Actions